ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

Senators Urge study section On Clinical Cancer Research

February 4, 1994

With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent

November 18, 2011

Roswell Park Wins $2.8 Million Grant

July 31, 2009

In Brief: NCI Planning 50th Anniversary In 1987, Seeks Information On Alumni For Observance In May

January 24, 1986

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976